October 2017
TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projectsAround our themes

In October Lyonbiopole’s news was busy: obtaining the Gold Label for the second time, launching the second call for projects with the HCL, positive results of the 24th call of the SIF (Single Inter-ministry Fund), mission to Japan, 11th edition of the Partnering Day ...

The end of the year will be as dense: appointment on November 14th during the 2017 Hospital-acquired infections day and on December 1st  for Private Inv€stments Day.

Cluster's life

  Lyonbiopole labeled for the 2nd time Gold Label!Lyonbiopole has just received for the second time the Gold label awarded by the European Cluster Excellence Initiative (ECEI). This second label makes Lyonbiopole one of the 87 most successful clusters in Europe. [...]
  Prospective themes and future medicine on the Lyonbiopole Partnering Day programThe 11th edition of Lyonbiopole Partnering Day was held at the Lyon Regional Hotel and gathered 250 participants. The flagship scientific event of Lyonbiopole addresses annually prospective themes. [...]
 Lyonbiopole’s Trade Mission in JapanFor the 4th year, Lyonbiopole successfully organize a trade mission for 6 of its members in Japan in October 2017. The mission was the opportunity for the companies to take part of the 2nd edition of the "European Biotech & Pharma Partnering conference" in Osaka (an event co-organize by the Osaka Bio Headquarters, bioXclusters PLUS alliance and the Eu-Japan Centre), and also to participate to Bio Japan 2017. Lyonbiopole is also supporting its members through their Gateway agreement sign in the framework of bioXclusters PLUS alliance with the cluster Osaka Bio Headquarters.
 Opening of Horizon 2020 Calls for proposalThe calls for proposals 2018 of the European funding programme for Research and Innovation, Horizon 2020, will open between the end of October and the beginning of November. Lyonbiopole, together with the HCL and the UCBL, organised an infoday to present the new Horizon 2020 calls dedicated to Health. These calls will open on November 7, as well as the SME Instrument (phase 1 and phase 2). Calls related to ICT, nutrition or nanotechnologies, advanced materials, biotechnology will open on 31 October. In order to make the search for these calls easier, Lyonbiopole has made a selection of the most relevant ones for the stakeholders working on the Health ecosystem. All information and deadlines for submission are available on Lyonbiopole’s website in the “forthcoming” call for projects section and below in our newsletter.
 INOVOLINE LABELLIZED BY LYONBIOPOLE AND RETAINED WITHIN THE FRAMEWORK OF 24th SIF Call for projects 3.2 M¤ INOVOLINE project approved for automated in vivo testing of new anticancer drugs ! Inovotion leads a consortium to automate and extend its unique Drug Discovery technology and develop a novel Personalised Medicine approach. The underlying technology is already a game changer for developing new anticancer drugs: in vivo efficacy and toxicity data in 1 month, x 5 affordable, x 1000 sensitivity, x 2 reliability, no animal testing, and it’s as predictive as other more classical models. The SFI (Single Inter-Ministery Fund) consortium includes Alprobotic expertise in robotics, UGA expertise for in vivo imaging, INRIA expertise in Automated Learning. Additionally, the Hospices Civils de Lyon will validate a novel Personalized Medicine approach. INOVOLINE leads the way to faster discovery of new cancer cures, and vastly improved patient care.

Our member's news

 New memberReference in the west of the Auvergne-Rhône-Alpes region, the University Hospital of Clermont-Ferrand (CHU Clermont-Ferrand) achieves several missions of care, teaching and clinical research on its three hospital sites (Hôpital Gabriel Montpied, Hôpital Estaing and Hôpital nord). […]
 New memberIXALTIS was created to develop and eventually market compounds alongside further products to be acquired through licensing/acquisition in the genitourinary sphere. The company's objective is to extend its portfolio, in order to become a leading developer of innovative pharmaceutical products for treating disorders of the urogenital tract, bringing […]
 New memberLaclarée develops electronic eyewear for presbyopia.  Based on a patented fluidic technology, Laclarée builds a product for people who have difficulty to wear progressive addition lenses, bringing them a better vision comfort. Laclarée’s technology will compensate the natural ageing of the eye, while being totally invisible and lightweight, thus insuring compatibility with stylish frames. […]
 Focus onOctober was a favorable month for fundraising in Auvergne-Rhônes-Alpes. Three of our members are part of these great results: Diabeloop raises ¤ 13.5 million including ¤ 7.5 million in private funds for its artificial pancreas, Bioserenity French champion of e-health raises ¤ 15 million and Biom'up, specialist in surgical haemostasis, succeeds its IPO by raising nearly ¤ 38.1 million on Euronext Paris. [...]
 October 13th, 2017ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC® October 16th, 2017GATTEFOSSÉ and CYTOO join forces October 17th, 2017Calais hospital center in the multimedia era
 October 17th, 2017IXALTIS expands development of Litoxetine to the USA October 24th, 2017Novasep Invests 4 Million Euros to Expand Its Cryogenic Production Capacity October 25th, 2017Success of Theranexus’ IPO on Euronext Growth in Paris
 October 27th, 2017ENYO Pharma opens a new subsidiary in Australia October 27th, 2017Biom’Up provides regulatory update regarding HEMOBLAST™ Bellows October 30th, 2017Sumitomo Dainippon Pharma and Poxel Announce Strategic Partnership

Save the date

  2017 Hospital-acquired infections day
November 14th, 2017
Private Inv¤stments Day
Décember 1st, 2017
  • Medica Copamed 2017
    November 13th, 2017
  • Immunotherapies for Infectious Diseases (I4ID2017)
    Décember 11th, 2017

  • See All events

    Calls for projects

     

    EUROPE & INTERNATIONAL

  • INTERREG IV A – France-Switzerland
    Before November 24th, 2017
  • SME Instrument (Phase 2)
    Before January 10th, 2018
  • H2020 NMBP (First Stage)
    Before January 23th, 2018
  • SME Instrument (Phase 1)
    Before February 8th, 2018
  • H2020 Food Security
    Before February 13th, 2018
  • Fast Track to Innovation (FTI)
    Before February 21th, 2018
  • H2020 Future Emerging Technologies
    Before March 22th, 2018
  • H2020 ICT
    Before April 17th, 2018
  • H2020 Santé / Call – Better Health and care, economic growth and sustainable health systems
    Before April 18th, 2018
  • H2020 Santé / Call – Digital transformation in Health and Care
    Before April 24th, 2018
  • H2020 Santé / Call – Trusted digital solutions and Cybersecurity in Health and Care
    Before April 24th, 2018
  • Around our themes

     
  • FALLING WALLS CONFERENCE
    November 8th, 2017
  • SLUSH
    November 30th, 2017
  • Pharmabiotics 2018
    March 14th, 2018
  • Bâtiment Domilyon

    321, avenue Jean Jaurès

    69007 Lyon

    Tel. : +33 (0)4 72 76 53 30

    Fax : +33 (0)9 55 91 30 26

    www.lyonbiopole.com

    info@lyonbiopole.com

    TwitterLinkedInrss

     

    This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.